Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2007919-60-8 | 2-Benzoyl-8-methyl-2,3-dihydroisoquinoline-1-carbonitrile | AA01EFKB | MFCD30471979
1242829-56-6 | methyl 4-[(morpholine-4-sulfonyl)methyl]benzoate | AA01EH3A | MFCD22438497
2096335-62-3 | [3-Chloro-5-(2-methoxyethoxy)phenyl]boronic acid | AA01EH8P | MFCD21609544
2096336-30-8 | 3-Ethoxy-2,4-difluoro-5-methylphenylboronic acid | AA01EHC1 | MFCD19981532
2096341-48-7 | 3-Chloro-5-fluoro-4-propoxyphenylboronic acid | AA01EHEY | MFCD20441801
2096334-10-8 | 3-(1-Cyanocyclopropyl)phenylboronic acid | AA01EHI1 | MFCD18914496
2096340-23-5 | 4-Chloro-2-(N-cyclohexylaminomethyl)phenylboronic acid, pinacol ester | AA01EHL6 | MFCD20441915
2096331-91-6 | [3-(Benzyloxy)-2,4-difluoro-5-methylphenyl]boronic acid | AA01EHNQ | MFCD20231453
723285-17-4 | N-benzyl-2-methylaniline hydrochloride | AA01EHR7 | MFCD11844399
2126143-63-1 | rac-tert-butyl N-{2-[(3R,4R)-4-methylpyrrolidin-3-yl]ethyl}carbamate, trans | AA01EHVL | MFCD30834003